United States - English - NLM (National Library of Medicine)

bryant ranch prepack - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine extended-release tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - felodipine - tablets extended release - felodipine 10 mg - felodipine - felodipine - moderate to severe hypertension. angina pectoris.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - felodipine - tablets extended release - felodipine 5 mg - felodipine - felodipine - moderade to severe hypertension.angina pectoris.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - felodipine - tablets extended release - felodipine 2.5 mg - felodipine - felodipine - hypertension. angina pectoris.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - felodipine, quantity: 10 mg - tablet, modified release - excipient ingredients: magnesium stearate; hypromellose; colloidal anhydrous silica; lactose monohydrate; titanium dioxide; purified talc; povidone; propyl gallate; iron oxide yellow; propylene glycol; iron oxide red; microcrystalline cellulose - hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - felodipine, quantity: 5 mg - tablet, modified release - excipient ingredients: hypromellose; iron oxide red; lactose monohydrate; titanium dioxide; propyl gallate; iron oxide yellow; purified talc; colloidal anhydrous silica; microcrystalline cellulose; povidone; propylene glycol; magnesium stearate - hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - felodipine -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - felodipine -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - felodipine -

United States - English - NLM (National Library of Medicine)

carilion materials management - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and with different